Peter P. Mueller
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
COVID-19 epidemiological studies, Pneumonia and Respiratory Infections, Hepatitis C virus research, Opioid Use Disorder Treatment, Data-Driven Disease Surveillance
Most-Cited Works
- → Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States(2019)279 cited
- → What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size(2022)216 cited
- → A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose(2020)99 cited
- → Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model(2018)60 cited
- → Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States(2023)37 cited
- Development of peak performance in track cycling.(2001)
- → Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication(2022)34 cited
- → Challenges of COVID-19 Case Forecasting in the US, 2020–2021(2024)30 cited
- → Hep C Calculator: an online tool for cost-effectiveness analysis of DAAs(2018)24 cited
- → Projecting COVID-19 Mortality as States Relax Nonpharmacologic Interventions(2022)23 cited